Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
| Metastatic renal cell carcinoma : Therapeutic concepts for non-medicinal ... - UroToday |
|
|
|
UroToday Metastatic renal cell carcinoma has a poor prognosis with a median overall survival rate of approximately 2 years. The current standard medicinal therapy includes the use of tyrosine kinase inhibitors or antiangiogenic substances, such as VEGF receptor |
Professional dialysis recruitment

